Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand?
D'Arena G, Sgambato A, Volpe S, Coppola G, Amodeo R, Tirino V, D'Auria F, Statuto T, Valvano L, Pietrantuono G, Deaglio S, Efremov D, Laurenti L, Aiello A.
D'Arena G, et al. Among authors: aiello a.
Hematol Oncol. 2022 Dec;40(5):835-842. doi: 10.1002/hon.3037. Epub 2022 Jun 21.
Hematol Oncol. 2022.
PMID: 35667043
Review.